Roivant Sciences Ltd

NASDAQ:ROIV  
4.43
+0.36 (+8.85%)
Products

FDA Approves Dermavant's Vtama Cream, 1% For Treatment Of Plaque Psoriasis In Adults

Published: 05/24/2022 10:25 GMT
Roivant Sciences Ltd (ROIV) - FDA Approves Dermavant’s Vtama® (tapinarof) Cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years.